Exenatide
Showing 26 - 50 of 425
Type2 Diabetes Trial in Evansville (Bexagliflozin, Exenatide Injection)
Completed
- Type2 Diabetes Mellitus
- Bexagliflozin
- Exenatide Injection
-
Evansville, IndianaClinical Research Site
May 5, 2021
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
Recruiting
- Type 2 Diabetes Mellitus
- Cardiovascular Diseases
- SU
- +13 more
-
Oakland, California
- +5 more
Oct 18, 2022
Cerebral Small Vessel Disease Trial in Hong Kong (Exenatide extended release)
Recruiting
- Cerebral Small Vessel Disease
- Exenatide extended release
-
Hong Kong, Hong KongChinese University of Hong Kong
Jul 18, 2022
Acute Ischemic Stroke Trial in Australia, Finland, New Zealand (Exenatide Injection)
Active, not recruiting
- Acute Ischemic Stroke
- Exenatide Injection
-
Darlinghurst, New South Wales, Australia
- +14 more
Sep 7, 2021
Obesity Trial in Salzburg, Uppsala (Exenatide, Placebo)
Completed
- Obesity
- Exenatide
- Placebo
-
Salzburg, Austria
- +1 more
May 17, 2022
Type 2 Diabetes, Obesity Trial in Cambridge (0.9% Sodium-chloride, Exenatide (50ng/min for 30 minutes loading followed by
Recruiting
- Type 2 Diabetes
- Obesity
- 0.9% Sodium-chloride
- +3 more
-
Cambridge, Cambridgeshire, United KingdomCambridge University Hospitals NHS Foundation Trust and The Univ
Jan 18, 2022
Type 2 Diabetes, Obesity Trial in Amsterdam (Dapagliflozin 10mg, Exenatide, exenatide)
Completed
- Type 2 Diabetes Mellitus
- Obesity
- Dapagliflozin 10mg
- +3 more
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, location VU Medical Center
Jun 8, 2021
Obesity Trial in Changsha (Liraglutide, Exenatide, Exenatide Microspheres for Injection)
Recruiting
- Obesity
- Liraglutide
- +2 more
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Apr 7, 2021
Quality of Life Trial in Besançon (Exenatide, Insulin)
Completed
- Quality of Life
- Exenatide
- Insulin
-
Besançon, FrancePost operative intensive care unit of the cardiac surgery depart
Mar 5, 2021
Smoking Cessation Trial in Houston (Exenatide, NRT, Counseling)
Completed
- Smoking Cessation
- Exenatide
- +3 more
-
Houston, TexasThe University of Texas Health Science Center at Houston
Jan 26, 2021
Cardiovascular Diseases Trial in Cambridge (Saline 0.9%, Glucagon (25ng/kg/min), Glucagon (50ng/kg/min))
Recruiting
- Cardiovascular Diseases
- Saline 0.9%
- +3 more
-
Cambridge, Cambridgeshire, United KingdomAddenbrooke's Hospital
Dec 10, 2021
Children and Adolescent With Type 2 Diabetes Trial in Worldwide (Exenatide Once Weekly, Placebo)
Completed
- Children and Adolescent With Type 2 Diabetes
- Exenatide Once Weekly
- Placebo
-
Los Angeles, California
- +34 more
Nov 2, 2021
Childhood Obesity Trial in Seattle (Family Based Behavioral Treatment, Exenatide 2 mg [Bydureon], Placebo)
Recruiting
- Childhood Obesity
- Family Based Behavioral Treatment
- +2 more
-
Seattle, WashingtonSeattle Children's Hospital
Aug 30, 2021
Severe Obesity Trial in Minneapolis (Weight loss with pharmacotherapy, Weight loss without pharmacotherapy)
Completed
- Severe Obesity
- Weight loss with pharmacotherapy
- Weight loss without pharmacotherapy
-
Minneapolis, MinnesotaUniversity of Minnesota
Dec 1, 2021
Atherosclerosis, Diabetes, Restenosis Trial in Stockholm (Bydureon, Humulin kwickpen, Metformin)
Recruiting
- Atherosclerosis
- +2 more
- Bydureon
- +2 more
-
Stockholm, Other, SwedenDept of clinical science and education Karolinska Institutet Söd
Aug 31, 2021
Four Second Line Pharmacological Strategies in Type 2 Diabetes
Active, not recruiting
- Cardiovascular Events
- +2 more
- SGLT2 inhibitor
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Feb 17, 2022
Early Parkinson's Disease Trial in Seongnam-si, Seoul (PT320 2.0mg Placebo, PT320 2.0 mg, PT320 2.5 mg)
Active, not recruiting
- Early Parkinson's Disease
- PT320 2.0mg Placebo
- +2 more
-
Seongnam-si, Korea, Republic of
- +4 more
Apr 7, 2021
Diabetes Trial in Boston (Albiglutide 50mg, Albiglutide matching , Exenatide 10microgram)
Terminated
- Diabetes Mellitus
- Albiglutide 50mg
- +3 more
-
Boston, MassachusettsGSK Investigational Site
Oct 8, 2020
Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism Trial in Barcelona (Experimental: GLP1-RA (exenatide)
Recruiting
- Hypopituitarism
- +7 more
- Experimental: GLP1-RA (exenatide) administration
- Control: Placebo administration
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Mar 18, 2022
Ischemic Stroke Trial in Herlev (Byetta, Normosaline)
Recruiting
- Ischemic Stroke
-
Herlev, DenmarkDepartment of Neurology, Herlev-Gentofte Hospital
Nov 13, 2021
Type 2 Diabetes, Chronic Kidney Disease, Left Ventricular Diastolic Dysfunction Trial in Dallas (BYDUREON, Placebo)
Completed
- Type 2 Diabetes Mellitus
- +2 more
- BYDUREON
- Placebo
-
Dallas, TexasBaylor Scott and White Research Institute- Baylor Heart and Vasc
Jan 25, 2021
Diabetes, Type 2 Trial in Louisville, Dallas (Exenatide, Albiglutide)
Type 2 Diabetes, Incretinomimetics, Pancreas Trial in Brussels (Incretinomimetics, DPP-4 inhibitors)
Recruiting
- Type 2 Diabetes
- +2 more
- Incretinomimetics
- DPP-4 inhibitors
-
Brussels, BelgiumGastroenterology Department Erasme Hospital
Mar 1, 2021
Multiple System Atrophy Trial in London (Exenatide Pen Injector [Bydureon])
Recruiting
- Multiple System Atrophy
- Exenatide Pen Injector [Bydureon]
-
London, United KingdomLeonard Wolfson Experimental Neurology Centre, National Hospital
Nov 4, 2020
Cocaine Dependence Trial in New Haven (cocaine HCl, exenatide, )
Completed
- Cocaine Dependence
- cocaine hydrochloride
- +2 more
-
New Haven, ConnecticutConnecticut Mental Health Center
Feb 25, 2021